-+ 0.00%
-+ 0.00%
-+ 0.00%

Stoke Therapeutics grants new hires options for 106,200 shares at $30.08

PUBT·05/18/2026 20:01:24
Listen to the news
Stoke Therapeutics grants new hires options for 106,200 shares at $30.08
  • Stoke Therapeutics granted stock options covering 106,200 common shares to eight new employees, effective May 15, 2026.
  • Exercise price set at USD 30.08 per share, matching the May 15 closing price.
  • Vesting structured over four years, with 25% vesting after one year then monthly vesting over the next 36 months, subject to continued employment.
  • Options carry a 10-year term under the 2023 Inducement Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605181601BIZWIRE_USPR_____20260518_BW928499) on May 18, 2026, and is solely responsible for the information contained therein.